Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Patrizia Giannatempo, Alberto Briganti, Luigi Mariani, Daniele Raggi, Andrea Necchi, Francesco Montorsi, Antonella Messina, Andrea Anichini
Publikováno v:
Journal of Clinical Oncology. 36:TPS534-TPS534
TPS534 Background: MIUBC is a systemic disease and > 40% of pts develop recurrence after Cy. Despite neoadjuvant chemotherapy yields Level 1 evidence, it is underutilized worldwide and a small survival improvement is deemed over Cy alone. PEM (MK-347
Autor:
Srikala S. Sridhar, Girish S. Kulkarni, Alexandre R. Zlotta, Miriam Teich, Peter Chung, Nimira S. Alimohamed, Robert G. Bristow, Shaheena Bashir, Neil Fleshner, Gregory Lo
Publikováno v:
Journal of Clinical Oncology. 34:417-417
417 Background: Neoadjuvant chemotherapy (NC) improves survival in MIBC pts regardless of local management-cystectomy or chemoradiation. NC use with chemoradiation has been limited as these pts are often elderly, frail and cisplatin-ineligible. But,
Autor:
Bas W.G. van Rhijn, Elsbeth van der Laan, Andre M. Bergman, Barry Doodeman, Simon Horenblas, Elisabeth E. Fransen van de Putte, Floris J. Pos, Michiel S. van der Heijden, J.M. Kerst
Publikováno v:
Journal of Clinical Oncology. 34:392-392
392 Background: Radical Cystectomy (RC) is the standard treatment of Invasive Bladder Cancer (IBC). Although organ sparing, external beam Radiation Treatment (RT) alone is considered inferior to RC. Since the Epidermal Growth Factor receptor (EGFr) i